Shareholder alert: pomerantz law firm reminds shareholders with losses on their investment in revance therapeutics, inc. of class action lawsuit and upcoming deadline - rvnc

New york, new york--(newsfile corp. - january 25, 2022) -  pomerantz llp announces that a class action lawsuit has been filed against revance therapeutics, inc. ("revance" or the "company") (nasdaq: rvnc) and certain of its officers. the class action, filed in the united states district court for the northern district of california, and docketed under 21-cv-09585, is on behalf of a class consisting of all persons and entities other than defendants that purchased...
RVNC Ratings Summary
RVNC Quant Ranking